Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration.

Compared with patients with no documented booster, patients who received a booster dose had reduced odds of severe COVID-19 in the full cohort (aOR, 0.73; 95% CI, 0.62-0.86) ( Table 2 ), but this observation typically did not reach statistical significance in subgroups (eTables 2-9 in Supplement 1 ).

also in 111,027 other papers